BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
33 hedge funds and large institutions have $48.9M invested in BioAmber Inc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
35% more capital invested
Capital invested by funds: $36.2M → $48.9M (+$12.8M)
0% more funds holding
Funds holding: 33 → 33 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$462K |
| 2 |
Renaissance Technologies
New York
|
+$208K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$105K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$78.6K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$69.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$852K |
| 2 |
RA
Royce & Associates
New York
|
-$665K |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$636K |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$149K |
| 5 |
LCS
Levin Capital Strategies
New York
|
-$95.6K |
BIOA Hedge Fund Activity: Q3 2016 in Review
33 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q3 2016, worth a combined $48.9M — up 35% from $36.2M a quarter earlier.
Fund positioning in BIOA was balanced in Q3 2016: 2 funds opened new positions, 2 closed out, 12 added to existing stakes and 8 trimmed.
The largest buyer was Bridgeway Capital Management, adding an estimated $462K. The largest seller was Federated Hermes, cutting an estimated $852K.
- 33 institutional investors held BioAmber Inc. (BIOA) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $48.9M of BioAmber Inc. stock for Q3 2016, up 35% quarter-over-quarter.
- 2 funds opened new BioAmber Inc. positions in Q3 2016 and 2 closed out, a net change of 0 holders.
- The largest BioAmber Inc. buyer in Q3 2016 was Bridgeway Capital Management, an estimated $462K added.
- The largest BioAmber Inc. seller in Q3 2016 was Federated Hermes, an estimated $852K sold.
Based on aggregated 13F filings for Q3 2016.